Announces completion of payment for warrants-attached convertible bonds. The 5th unsecured convertible bond with stock acquisition rights totals 187,200,000 yen, interest rate 1.0% per annum, maturity date November 2, 2029, and potential shares amount to 687,830 shares. Allottee is Cantor Fitzgerald Europe. Third-party allotment of warrants-attached bonds and new shares was executed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4572","jir_company_name":"Carna Biosciences, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-04","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4572-20261104-01.pdf","jir_short_summary":"Announces completion of payment for warrants-attached convertible bonds. The 5th unsecured convertible bond with stock acquisition rights totals 187,200,000 yen, interest rate 1.0% per annum, maturity date November 2, 2029, and potential shares amount to 687,830 shares. Allottee is Cantor Fitzgerald Europe. Third-party allotment of warrants-attached bonds and new shares was executed.","jir_summary":"### Overview\nCarna Biosciences, Inc. announced the completion of payment for the 5th unsecured convertible bond with stock acquisition rights issued by third-party allotment. The allottee is Cantor Fitzgerald Europe, and the total amount is 187,200,000 yen. There are 40 warrants, corresponding to 687,830 potential shares upon conversion. The interest rate is 1.0% per annum and the maturity date is November 2, 2029.\n\n### Allottee, Procedures and Future Actions\nThe issuance of the warrants-attached convertible bonds was conducted as a third-party allotment under the warrants-attached bond issuance program agreement, with Cantor Fitzgerald Europe as the allottee. The conversion price for the warrants is 302.4 yen, and no price adjustment clause is attached. Payment has been completed; note that any future financing cycles or additional financings will require approval from the allottee.","jir_financial_highlights":"Total amount of bonds: 187,200,000 yen (Unknown)\nTotal number of warrants: 40 units (Unknown)\nInterest rate: Annual 1.0% (Unknown)\nMaturity date: 2029-11-02 (Unknown)\nPotential number of shares: 687,830 shares (Unknown)","jir_category":"","jir_hashtags":"#CarnaBiosciences, #CapitalPolicyAndFinance, #ThirdPartyAllotment","jir_key_figures":"187,200,000 yen: Total amount of bonds\n40 units: Total number of warrants\n687,830 shares: Potential number of shares","jir_meta_title":"Carna Biosciences, Inc. Announces Completion of Payment for 5th Warrant-Attached Convertible Bonds\uff5cNovember 2026","jir_meta_description":"Carna Biosciences, Inc. announced completion of payment for the 5th unsecured convertible bond with stock acquisition rights by third-party allotment. Allottee: Cantor Fitzgerald Europe; total 187,200,000 yen; interest rate 1.0%; maturity November 2, 2029; potential shares 687,830 shares.","jir_og_title":"Carna Biosciences, Inc.\uff5cAnnounces Completion of Payment for Warrant-Attached Convertible Bonds","jir_og_description":"Carna Biosciences, Inc. announced completion of payment for third-party allotted warrant-attached convertible bonds. Allottee: Cantor Fitzgerald Europe. Total 187,200,000 yen; potential shares 687,830 shares.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59427,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-141414","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n